Kishi Taro 岸太郎

… Alternative Names

岸太郎キシタロウ

KISHI Taro 岸太郎

Less

Researcher Number	40536801
Other IDs	https://orcid.org/0000-0002-9237-2236
Affiliation (Current)	2025: 藤田医科大学, 医学部, 教授
Affiliation (based on the past Project Information) *help	2025: 藤田医科大学, 医学部, 教授 2019 – 2023: 藤田医科大学, 医学部, 准教授 2013 – 2014: 藤田保健衛生大学, 医学部, 講師
Review Section/Research Field	Principal Investigator Basic Section 52030:Psychiatry-related / Psychiatric science Except Principal Investigator Basic Section 52030:Psychiatry-related
Keywords	Principal Investigator 再発 / 持効性注射薬 / 有害事象のため持効性注射薬による治療tの中断 / 非定型抗精神病薬の持効性注射薬 / 双極症 / 統合失調症 / 経口抗精神病薬 / 抗精神病薬持効性注射薬 / 無作為割付試験 / 大うつ病性障害と … More / 安全性 / 効果 / パロキセチン徐放製剤 / エスシタロプラム / 大うつ病性障害 … More Except Principal Investigator 無作為化比較試験 / ネットワークメタ解析 / 大うつ病性障害 / 治療ガイドライン / メタ解析 / 系統的レビュー / 維持期治療 / うつ病 Less

双極症うつ病に対する治療戦略の最適化：系統的レビューとメタ解析Principal Investigator
- Principal Investigator
  
  岸太郎
- Project Period (FY)
  2025 – 2027
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Fujita Health University
維持期うつ病に対する様々な治療方法の有用性の検討：ネットワークメタ解析
- Principal Investigator
  
  佐久間健二
- Project Period (FY)
  2023 – 2025
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Fujita Health University
Antipsychotic treatment and rehospitalization of schizophrenia patients: a cohort studyPrincipal Investigator
- Principal Investigator
  
  岸太郎
- Project Period (FY)
  2019 – 2024
- Research Category
  
  Grant-in-Aid for Scientific Research (C)
- Review Section
  
  Basic Section 52030:Psychiatry-related
- Research Institution
  Fujita Health University
fficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialPrincipal Investigator
- Principal Investigator
  
  KISHI Taro
- Project Period (FY)
  2013 – 2014
- Research Category
  
  Grant-in-Aid for Young Scientists (B)
- Research Field
  
  Psychiatric science
- Research Institution
  Fujita Health University

All 2024 2022 2021 2020 2015 2014 2013

All Journal Article

[Journal Article] A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.2024
- Author(s)
  Kishi T, Citrome L, Sakuma K, Iwata N.
- Journal Title
  
  Psychiatry Res.
  
  Volume: Mar Pages: 333-333
- DOI
  10.1016/j.psychres.2024.115761
- Peer Reviewed / Int'l Joint Research
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis2022
- Author(s)
  Taro Kishi, Kenji Sakuma, Nakao Iwata
- Journal Title
  
  Transl Psychiatry .
  
  Volume: 19 Issue: 1 Pages: 1-6
- DOI
  10.1038/s41398-022-02286-1
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia2021
- Author(s)
  Kishi T, Sakuma K, Okuya M, Iwata N.
- Journal Title
  
  J Psychiatr Res.
  
  Volume: 132 Pages: 144-150
- DOI
  10.1016/j.jpsychires.2020.10.009
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Duration of long-acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia2021
- Author(s)
  Taro Kishi, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Nakao Iwata
- Journal Title
  
  Psychiatry Clin Neurosci .
  
  Volume: in press Issue: 7 Pages: 240-241
- DOI
  10.1111/pcn.13222
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review2021
- Author(s)
  Taro Kishi, Kenji Sakuma, Makoto Okuya, Masakazu Hatano, Nakao Iwata
- Journal Title
  
  Neuropsychopharmacol Rep .
  
  Volume: 41 Issue: 3 Pages: 422-425
- DOI
  10.1002/npr2.12192
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.2020
- Author(s)
  Kishi T, Yoshimura R, Matsuda Y, Sakuma K, Iwata N.
- Journal Title
  
  Pharmacopsychiatry
  
  Volume: in press Issue: 03 Pages: 122-132
- DOI
  10.1055/a-1096-1266
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-19K08082
[Journal Article] Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.2015
- Author(s)
  Kishi T, Matsuda Y, Matsunaga S, Iwata N.
- Journal Title
  
  Neuropsychiatr Dis Treat
  
  Volume: 20 Pages: 419-34
- DOI
  10.2147/ndt.s78977
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25861033, KAKENHI-PROJECT-26860949
[Journal Article] Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.2014
- Author(s)
  Kishi T, Matsuda Y, Iwata N.
- Journal Title
  
  PLoS One
  
  Volume: 4 Issue: 2 Pages: 1-2
- DOI
  10.1371/journal.pone.0088049
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.2014
- Author(s)
  Kishi T, Meltzer HY, Matsuda Y, Iwata N.
- Journal Title
  
  Psychol Med
  
  Volume: 44 Pages: 2255-69
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia.2014
- Author(s)
  Kishi T, Iwata N.
- Journal Title
  
  Int J Neuropsychopharmacol.
  
  Volume: 17 Issue: 02 Pages: 343-54
- DOI
  10.1017/s1461145713000667
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.2014
- Author(s)
  Kishi T, Mukai T, Matsuda Y, Iwata N.
- Journal Title
  
  Neuromolecular Med
  
  Volume: 16 Issue: 1 Pages: 61-9
- DOI
  10.1007/s12017-013-8251-0
- Peer Reviewed / Open Access
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.2013
- Author(s)
  Kishi T, Meltzer HY, Matsuda Y, Iwata N.
- Journal Title
  
  Psychol Med.
  
  Volume: 21 Pages: 1-15
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Antipsychotics for cocaine or psychostimulant dependence: systematic review and meta-analysis of randomized, placebo-controlled trials.2013
- Author(s)
  Kishi T, Matsuda Y, Iwata N, Correll CU.
- Journal Title
  
  J Clin Psychiatry
  
  Volume: 74 Issue: 12 Pages: 1169-80
- DOI
  10.4088/jcp.13r08525
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Antipsychotics for primary alcohol dependence: a systematic review and meta-analysis of placebo-controlled trials.2013
- Author(s)
  Kishi T, Sevy S, Chekuri R, Correll CU.
- Journal Title
  
  J Clin Psychiatry.
  
  Volume: 74 Issue: 07 Pages: 642-54
- DOI
  10.4088/jcp.12r08178
- Data Source
  KAKENHI-PROJECT-25861033
[Journal Article] Efficacy and safety of noradrenalin reuptake inhibitor augmentation therapy for schizophrenia: a meta-analysis of double-blind randomized placebo-controlled trials.2013
- Author(s)
  Kishi T, Mukai T, Matsuda Y, Moriwaki M, Iwata N.
- Journal Title
  
  J Psychiatr Res
  
  Volume: 47 Issue: 11 Pages: 1557-63
- DOI
  10.1016/j.jpsychires.2013.07.003
- Peer Reviewed
- Data Source
  KAKENHI-PROJECT-25861033

1. 佐久間健二 (70838317)

# of Collaborated Projects: 1 results

# of Collaborated Products: 0 results

Kishi Taro 岸 太郎

岸 太郎 キシ タロウ

KISHI Taro 岸 太郎

Research Projects

Research Products

Co-Researchers

双極症うつ病に対する治療戦略の最適化：系統的レビューとメタ解析Principal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

維持期うつ病に対する様々な治療方法の有用性の検討：ネットワークメタ解析

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

Antipsychotic treatment and rehospitalization of schizophrenia patients: a cohort studyPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Review Section

Research Institution

fficacy and tolerability of escitalopram versus paroxetine-CR in Japanese patients with major depressive disorder: a randomized, masked-rater trialPrincipal Investigator

Principal Investigator

Project Period (FY)

Research Category

Research Field

Research Institution

[Journal Article] A comparison of recurrence rates after discontinuation of second-generation antipsychotic long-acting injectable versus corresponding oral antipsychotic in the maintenance treatment of bipolar disorder: A systematic review.2024

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Paliperidone palmitate vs. paliperidone extended-release for the acute treatment of adults with schizophrenia: a systematic review and pairwise and network meta-analysis2022

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Association between discontinuation due to withdrawal of consent and use of long-acting injectable antipsychotics: A meta-analysis of randomized trials for schizophrenia2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Duration of long-acting injectable antipsychotic treatment and reasons for its discontinuation: A chart review of patients with schizophrenia2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Outcomes of patients with schizophrenia who discontinued long-acting injectable antipsychotic therapy due to adverse events: A chart review2021

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Blonanserin patch vs. Other Antipsychotics for Acute Schizophrenia: A Systematic Review of Double-blind, Randomized, Placebo-controlled, Phase 3 Trials in Japan.2020

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Aripiprazole for the management of schizophrenia in the Japanese population: a systematic review and meta-analysis of randomized controlled trials.2015

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Cardiometabolic risks of blonanserin and perospirone in the management of schizophrenia: a systematic review and meta-analysis of randomized controlled trials.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Azapirone 5-HT1A receptor partial agonist treatment for major depressive disorder: systematic review and meta-analysis.2014

Author(s)

Journal Title

Data Source

[Journal Article] Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia.2014

Author(s)

Journal Title

DOI

Data Source

[Journal Article] Selective serotonin 3 receptor antagonist treatment for schizophrenia: meta-analysis and systematic review.2014

Kishi Taro 岸太郎

岸太郎キシタロウ

KISHI Taro 岸太郎